Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 7.230% | 16.667% | -7.290% | 291.653% | 297.140% | 1294.658% | - |
| Alpine Immune Sciences Inc | -1.650% | -0.820% | 74.855% | 830.769% | 237.989% | 587.500% | 643.974% |
| Eli Lilly Corp. | 1.380% | 0.543% | -4.368% | 100.938% | 29.773% | 342.207% | 538.583% |
| Catalyst Pharmaceutical Partners Inc | -2.360% | -5.782% | -5.878% | -5.133% | -11.390% | 260.660% | 175.400% |
| Geron Corp. | 7.910% | 2.018% | 16.305% | 60.965% | 79.776% | 184.177% | 114.554% |
| Cytokinetics Inc. | 1.650% | -3.150% | -7.519% | 76.724% | -19.608% | 179.545% | - |
| Intra-Cellular Therapies Inc. | 1.480% | 1.471% | 10.048% | 24.549% | 5.828% | 152.009% | 564.356% |
| Savara Inc. | -3.030% | -14.403% | -6.726% | 152.121% | -2.804% | 144.706% | -56.362% |
| Medpace Holdings Inc | -3.440% | 4.008% | -2.207% | 96.591% | 29.288% | 125.652% | - |
| Vertex Pharmaceuticals Inc. | 0.200% | 0.324% | -3.944% | 26.779% | -0.067% | 106.885% | 140.513% |
| EyePoint Pharmaceuticals Inc. | 3.150% | -4.985% | -18.168% | 150.080% | -26.963% | 100.385% | - |
| Regeneron Pharmaceuticals Inc. | -0.600% | -1.902% | -7.281% | 17.050% | 3.473% | 99.083% | 169.102% |
| Sarepta Therapeutics | 1.770% | 10.871% | 1.604% | 8.570% | 36.019% | 98.729% | 10.413% |
| Merck & Co. Inc. | 0.820% | 3.723% | 1.997% | 19.261% | 24.467% | 91.204% | 78.717% |
| Collegium Pharmaceutical Inc | 1.230% | 1.852% | -8.840% | 61.765% | 20.438% | 74.603% | - |
| Madrigal Pharmaceuticals inc. | -0.910% | -9.216% | -20.897% | -33.006% | -14.499% | 68.925% | 85.651% |
| AbbVie Inc. | -4.160% | -4.443% | -9.758% | 1.814% | 6.538% | 61.993% | 109.311% |
| Voyager Therapeutics Inc | 4.410% | -1.656% | -16.667% | 4.015% | -10.377% | 58.052% | - |
| Neurocrine Bioscience | -0.510% | 2.542% | -2.494% | 36.466% | 6.496% | 55.470% | 93.615% |
| Capricor Therapeutics Inc | 6.580% | 7.987% | -17.561% | 42.416% | 13.296% | 53.636% | - |